Worldwide Veterinary Oncology Industry to 2025 - Surge in Awareness Related to Animal Healthcare Presents Opportunities

DUBLIN, June 16, 2021 /PRNewswire/ -- The "Global Veterinary Oncology Market (2020-2025) by Type, Animal Type, Therapy Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis" report has been added to ResearchAndMarkets.com's offering.

The Global Veterinary Oncology Market is estimated to be USD 60.44 Mn in 2020 and is expected to reach USD 86.75 Mn by 2025, growing at a CAGR of 7.5%.



The key factors driving the growth of this market include upsurge in the prevalence of cancer in pets, increasing research and investments in pet cancer, growing focus on animal safety whereas high cost associated with chemotherapies, immunotherapies, and targeted therapies are major factors restraining the veterinary oncology market growth.



Recent Developments

1. Boehringer Ingelheim took over AMAL Therapeutics, a biotechnology company focused on cancer immunotherapy. The acquisition helped the company to become an innovator of novel cancer therapies, including immuno-oncology treatments. July 2019.

2. Elanco acquired Aratana Therapeutics in April 2019, after which, the company declared the formation of a commercial team devoted to the veterinary specialty business.

3. Another contribution by the market player in August 2019, was the initiation of Phase 2 clinical trial by PharmAust in Australia with its leading veterinary drug candidate, monepantel, to treat canine cancer.



Company Profiles



Some of the companies covered in this report are Boehringer Ingelheim International GmbH, Karyopharm Therapeutics, Inc., Regeneus Ltd., Elanco Animal Health, Inc., Zoetis, Inc., Varian Medical Systems, Inc., PetCure Oncology, LLC (Accelitech, LLC), AB Science SA, Rhizen Pharmaceuticals S.A., and Nippon Zenyaku Kogyo Co., Ltd., etc.



Competitive Quadrant



The report includes a Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.



Why buy this report?

• The report offers a comprehensive evaluation of the Global Veterinary Oncology Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
• The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
• The report includes in-depth market analysis using Porter's 5 force model and the Ansoff Matrix. The impact of Covid-19 on the market is also featured in the report.
• The report also contains the competitive analysis using the Competitive Quadrant, the analyst's proprietary competitive positioning tool.

Report Highlights:

• A complete analysis of the market, including parent industry
• Important market dynamics and trends
• Market segmentation
• Historical, current, and projected size of the market based on value and volume
• Market shares and strategies of key players
• Recommendations to companies for strengthening their foothold in the market

Key Topics Covered:



1 Report Description



2 Research Methodology



3 Executive Summary



4 Market Overview

4.1 Introduction

4.2 Market Dynamics

4.2.1 Drivers

4.2.1.1 Upsurge in the prevalence of cancer in pets

4.2.1.2 Increasing research and investments in pet cancer

4.2.1.3 Growing focus on animal safety

4.2.2 Restraints

4.2.2.1 High cost of pet cancer treatment

4.2.2.2 Lack of awareness among pet owners about pet disease

4.2.2.3 Adverse effects of drugs used for pet cancer treatment

4.2.3 Opportunities

4.2.3.1 Surge in Awareness Related to Animal Healthcare

4.2.4 Challenges

4.2.4.1 Lack of Standardization in Veterinary Cross

4.3 Trends



5 Market Analysis

5.1 Porter's Five Forces Analysis

5.2 Impact of COVID-19

5.3 Ansoff Matrix Analysis



6 Global Veterinary Oncology Market segment, By Type

6.1 Lymphoma

6.2 Mast Cell Cancer

6.3 Mammary and Squamous Cell Cancer

6.4 Others (Anal Sac Carcinoma)



7 Global Veterinary Oncology Market segment, By Animal

7.1 Companion Animal

7.2 Livestock Animal



8 Global Veterinary Oncology Market segment, By Therapy

8.1 Chemotherapy

8.2 Combination Therapy

8.3 Immunotherapy

8.4 Targeted Therapy



9 Global Veterinary Oncology segment Market, By Geography

9.1 Introduction

9.2 North America

9.2.1 US

9.2.2 Canada

9.2.3 Mexico

9.3 South America

9.3.1 Brazil

9.3.2 Argentina

9.4 Europe

9.4.1 UK

9.4.2 France

9.4.3 Germany

9.4.4 Italy

9.4.5 Spain

9.4.6 Rest of Europe

9.5 Asia-Pacific

9.5.1 China

9.5.2 Japan

9.5.3 India

9.5.4 Indonesia

9.5.5 Malaysia

9.5.6 South Korea

9.5.7 Australia

9.5.8 Russia

9.5.9 Rest of APAC

9.6 Rest of the World

9.6.1 Qatar

9.6.2 Saudi Arabia

9.6.3 South Africa

9.6.4 United Arab Emirates

9.6.5 Latin America



10 Competitive Landscape

10.1 Competitive Quadrant

10.2 Market Share Analysis

10.3 Competitive Scenario

10.3.1 Mergers & Acquisitions

10.3.2 Agreement, Collaborations, & Partnerships

10.3.3 New Product Launches & Enhancements

10.3.4 Investments & Funding



11 Company Profiles

11.1 Boehringer Ingelheim International GmbH

11.2 Elanco

11.3 Zoetis

11.4 PetCure Oncology

11.5 Accuray Incorporated

11.6 Varian Medical System, Inc.

11.7 Nippon Zenyaku Kogyo Co., Ltd.

11.8 Morphogenesis, Inc.

11.9 Karyopharm Therapeutics, Inc.,

11.10 Regeneus Ltd.

11.11 One Health

11.12 Zenoaq

11.13 VetDC

11.14 AdvaVet, Inc.

11.15 Rhizen Pharmaceutical SA.



12 Appendix

For more information about this report visit https://www.researchandmarkets.com/r/qag3z5

Media Contact:

Research and Markets

Laura Wood, Senior Manager

press@researchandmarkets.com   



For E.S.T Office Hours Call +1-917-300-0470

For U.S./CAN Toll Free Call +1-800-526-8630

For GMT Office Hours Call +353-1-416-8900



U.S. Fax: 646-607-1904

Fax (outside U.S.): +353-1-481-1716

View original content:http://www.prnewswire.com/news-releases/worldwide-veterinary-oncology-industry-to-2025---surge-in-awareness-related-to-animal-healthcare-presents-opportunities-301313990.html

SOURCE Research and Markets